A Randomized Trial of Cisplatin and Gemcitabine Alone or In Combination With Bevacizumab in Patients With Stage IIIB/IV EGFR Mutation-negative Non-squamous Non-Small Cell Lung Cance

Trial Profile

A Randomized Trial of Cisplatin and Gemcitabine Alone or In Combination With Bevacizumab in Patients With Stage IIIB/IV EGFR Mutation-negative Non-squamous Non-Small Cell Lung Cance

Recruiting
Phase of Trial: Phase II

Latest Information Update: 27 Feb 2017

At a glance

  • Drugs Bevacizumab (Primary) ; Cisplatin (Primary) ; Gemcitabine (Primary) ; GEM 122
  • Indications Non-small cell lung cancer
  • Focus Therapeutic Use
  • Most Recent Events

    • 01 Feb 2013 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov.
    • 23 Jun 2012 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top